Given the findings from the recent years that emphasize its significance in chronic kidney diseases as well as in inflammatory reaction, this review will focus on miR-21 and its therapeutic potential, as well as on its key upstream regulator—Smad3. Here, SMAD3 is linked to chronic kidney disease.